Source link : https://www.newshealth.biz/health-news/ozempic-shows-potential-for-alcohol-addiction-in-trial/
(MedPage Today) — Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving in adults with alcohol use disorder (AUD), a phase II randomized trial showed. At 9 weeks, semaglutide… Source link : https://www.medpagetoday.com/psychiatry/addictions/114191 Author : Publish date : 2025-02-12 18:44:07 Copyright for syndicated content belongs to the […]
Author : News Health
Publish date : 2025-02-12 18:44:07
Copyright for syndicated content belongs to the linked Source.